Research advances in the roles of EGFR and targeted therapy in triple negative breast cancer

doi:10.3781/j.issn.1000-7431.2023.2306-0301

PDF(1072 KB)

Tumor ›› 2023, Vol. 43 ›› Issue (10) : 829-838. DOI: 10.3781/j.issn.1000-7431.2023.2306-0301

Review

Research advances in the roles of EGFR and targeted therapy in triple negative breast cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 43(10): 829-838 https://doi.org/10.3781/j.issn.1000-7431.2023.2306-0301

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(1072 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2023-06-21	2023-10-23	2023-10-25
Issue Date
2023-10-25

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS